Elimination rate constant (K el ) indicates the rate at which a drug is removed from the body, which is found to be 0.09 and 0.08 h 1 , 0.08 and 0.084 h 1 , and 0.14 and 0.148 h 1 for i.v
The most practically important interaction involves GLP-1 agonists and oral medications
Subcutaneous NAD+: Offers high absorption, is self-administered, and ideal for maintaining NAD+ between IVs
The standard schedule keeps each injection at 2.8 mg: daily in weeks 14, five times per week in weeks 58, and two or three times weekly in weeks 912
Ipamorelin Best for: growth-hormone axis stimulation for lean mass and recovery support Ipamorelin is a synthetic pentapeptide (amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2) that belongs to the growth hormone secretagogue class, acting as a selective agonist at the ghrelin receptor (GHS-R1a) in the pituitary gland to stimulate pulsatile growth hormone release
Neurodegeneration research applications explore whether selective elimination of senescent glial cells could restore immune function and reduce neuroinflammation in aging brain models